Sample type:
Delivery period:
Antiepileptics DNA test
Epilepsy is a chronic disease of the brain, consisting of the transmission of abnormal electrical signals in the nervous system. This triggers epileptic seizures of very different types, for each of which there is a more appropriate medication.
The medication allows controlling the appearance of crises in 70-80% of the cases. Today it is considered to suspend the medication, with prudence, when the patient takes the necessary years, without crisis. Treatment is usually initiated with monotherapy, depending on the type of crisis to be treated, with the alternative of adding drugs in case of monotherapy failure.
Several factors determine the success of antiepileptic therapy. Some drugs are eliminated by enzymes encoded by genes that present polymorphisms, and therefore their activity may vary between patients.
In addition to the determination of genetic polymorphisms, it is important to assess interactions between drugs. There are many antiepileptics that are potent enzyme inducers, which can affect other drugs that are administered together for other indications, causing an alteration of their plasma levels.
The ANTIEPILEPTICSpgx profile studies the main categories and drugs related to the treatment of epilepsy. The report includes an interpretation of the results for the 20 most frequent prescription drugs.
Interpretation of the report in Polytherapy
In this report, the "green" labeling of a certain drug with the patient's genes indicates that it can be prescribed in the standard dose conditions disclosed in the prospectus or those recommended by the physician. This applies in the case of monotherapy.
However, if the patient takes several medications, which is very common, although in the report would appear in "green" can cause adverse effects due to possible interactions between them, which can sometimes be severe, either by toxicity or by therapeutic failure.
Drugs are chemicals that may interfere the normal metabolism of other drugs. Interferences that are also applicable to the chemical substances of various medicinal plants and food supplements.
Consequently, the whole of the medication, together with the consumer products or life habits of the patient, must undergo an evaluation of pharmacological interactions.
Consulting g-Nomic® Pharmacogenetics interpretation software, before prescribing, is an effective aid to avoid most adverse effects or therapeutic failures due to medication.
g-Nomic® interrelates all drugs, herbs, nutritional supplements and lifestyle, with the patient's genes. It also advises the most appropriate dose to prescribe.
This text has been translated automatically using an electronic translator, so the Spanish version should prevail. Please check in case of doubt.
You will receive the sample collection kit. You can request additional kits if you need it.
Sample collection kit content:
You will get a box with sample collection kit. Within the kit you will find:
- Saliva collector.
- Instructions for the sample collection.
- Required documents
- Security bag to enter the sample for shipment.
- Envelope bag.
Process to follow:
- Fill in the documents that we will send you, duly signed. You can also find these documents on this page, under the web tab: "Documents required".
- Follow the instructions for collecting the sample.
- After obtaining the sample, include it in the return envelope remember to put into the necessary documents.
- Call Eugenomic® on +34 93 292 29 63 or email info@eugenomic.com to request sample collection. No shipping costs on Spanish territory.
- An email confirmation will be sent when your sample si received.
- When the study will be completed you will receive a new e-mail to inform you that your report is already available in "My results"
Info producto mobile
Profile Information
Antiepileptics DNA test
Epilepsy is a chronic disease of the brain, consisting of the transmission of abnormal electrical signals in the nervous system. This triggers epileptic seizures of very different types, for each of which there is a more appropriate medication.
The medication allows controlling the appearance of crises in 70-80% of the cases. Today it is considered to suspend the medication, with prudence, when the patient takes the necessary years, without crisis. Treatment is usually initiated with monotherapy, depending on the type of crisis to be treated, with the alternative of adding drugs in case of monotherapy failure.
Several factors determine the success of antiepileptic therapy. Some drugs are eliminated by enzymes encoded by genes that present polymorphisms, and therefore their activity may vary between patients.
In addition to the determination of genetic polymorphisms, it is important to assess interactions between drugs. There are many antiepileptics that are potent enzyme inducers, which can affect other drugs that are administered together for other indications, causing an alteration of their plasma levels.
The ANTIEPILEPTICSpgx profile studies the main categories and drugs related to the treatment of epilepsy. The report includes an interpretation of the results for the 20 most frequent prescription drugs.
Interpretation of the report in Polytherapy
In this report, the "green" labeling of a certain drug with the patient's genes indicates that it can be prescribed in the standard dose conditions disclosed in the prospectus or those recommended by the physician. This applies in the case of monotherapy.
However, if the patient takes several medications, which is very common, although in the report would appear in "green" can cause adverse effects due to possible interactions between them, which can sometimes be severe, either by toxicity or by therapeutic failure.
Drugs are chemicals that may interfere the normal metabolism of other drugs. Interferences that are also applicable to the chemical substances of various medicinal plants and food supplements.
Consequently, the whole of the medication, together with the consumer products or life habits of the patient, must undergo an evaluation of pharmacological interactions.
Consulting g-Nomic® Pharmacogenetics interpretation software, before prescribing, is an effective aid to avoid most adverse effects or therapeutic failures due to medication.
g-Nomic® interrelates all drugs, herbs, nutritional supplements and lifestyle, with the patient's genes. It also advises the most appropriate dose to prescribe.
This text has been translated automatically using an electronic translator, so the Spanish version should prevail. Please check in case of doubt.
Sample type and process to follow
You will receive the sample collection kit. You can request additional kits if you need it.
Sample collection kit content:
You will get a box with sample collection kit. Within the kit you will find:
- Saliva collector.
- Instructions for the sample collection.
- Required documents
- Security bag to enter the sample for shipment.
- Envelope bag.
Process to follow:
- Fill in the documents that we will send you, duly signed. You can also find these documents on this page, under the web tab: "Documents required".
- Follow the instructions for collecting the sample.
- After obtaining the sample, include it in the return envelope remember to put into the necessary documents.
- Call Eugenomic® on +34 93 292 29 63 or email info@eugenomic.com to request sample collection. No shipping costs on Spanish territory.
- An email confirmation will be sent when your sample si received.
- When the study will be completed you will receive a new e-mail to inform you that your report is already available in "My results"